SMAR1 regulates free radical stress through modulation of AKR1a4 enzyme activity

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 7, 2010, Pages 1105-1114

  Singh, Sandeep ^a   Sreenath, Kadreppa ^a   Pavithra, Lakshminarasimhan ^a   Roy, Siddhartha ^b   Chattopadhyay, Samit ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

^b INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

AKR1a4; DNA damage; Free radical stress; Red blood cells; SMAR1

Indexed keywords

ALDOKETOREDUCTASE FAMILY 1 MEMBER A4; ATM PROTEIN; OXIDOREDUCTASE; PEPTIDE DERIVATIVE; PROTEIN SMAR1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; ALDEHYDE REDUCTASE; ALDEHYDE REDUCTASE AKR1A4, MOUSE; BANP PROTEIN, HUMAN; BANP PROTEIN, MOUSE; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; FREE RADICAL; NUCLEAR PROTEIN; PROTEIN BINDING;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CELL CYCLE ARREST; COMPLEX FORMATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DOWN REGULATION; EMBRYO; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; AMINO ACID SEQUENCE; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOLOGICAL MODEL; CELL NUCLEUS; CHEMISTRY; ENZYME ACTIVATION; HELA CELL LINE; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGICAL STRESS;

ALDEHYDE REDUCTASE; AMINO ACID SEQUENCE; ANIMALS; CELL CYCLE PROTEINS; CELL NUCLEUS; DNA DAMAGE; DNA-BINDING PROTEINS; ENZYME ACTIVATION; FREE RADICALS; HELA CELLS; HUMANS; MICE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN TRANSPORT; STRESS, PHYSIOLOGICAL;

EID: 77953535802     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2010.01.022     Document Type: Article

References (41)

1. Amer J., Goldfarb A., Fibach E. Flow cytometric measurement of reactive oxygen species production by normal and thalassaemic red blood cells. Eur J Haematol 2003, 70:84-90.
2. Beal M.F. Less stress, longer life. Nat Med 2005, 11:598-599.
3. Beg A.A., Ruben S.M., Scheinman R.I., Haskil S., Rosen C.A., Baldwin A.S. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. Genes Dev 1992, 6:1899-1913.
4. Bensaad K., Cheung E.C., Vousden K.H. Modulation of intracellular ROS levels by TIGAR controls autophagy. EMBO J 2009, 28(19):3015-3026.
5. Bensaad K., Tsuruta A., Selak M.A., Vidal M.N., Nakano K., Bartrons R., et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006, 126:107-120.
6. Canman C.E., Lim D.S. The role of ATM in DNA damage responses and cancer. Oncogene 1998, 17:3301-3308.
7. Chattopadhyay S., Kaul R., Charest A., Housman D., Chen J. SMAR1, a novel, alternatively spliced gene product, binds the Scaffold/Matrix-associated region at the T cell receptor beta locus. Genomics 2000, 68:93-96.
8. Chen Q., Chai Y.C., Mazumder S., Jiang C., Macklis R.M., Chisolm G.M., et al. The late increase in intracellular free radical oxygen species during apoptosis is associated with cytochrome c release, caspase activation, and mitochondrial dysfunction. Cell Death Differ 2003, 10:323-334.
9. Chen Z.X., Pervaiz S. Involvement of cytochrome c oxidase subunits Va and Vb in the regulation of cancer cell metabolism by Bcl-2. CDD 2009, 1-13.
10. Dolado I., Nebreda A.R. AKT and oxidative stress team up to kill cancer cells. Cancer Cell 2008, 14(6):427-429.
11. Ganchi P.A., Sun S.C., Greene W.C., Ballard D.W. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding. Mol Biol Cell 1992, 3:1339-1352.
12. Henkel T., Zabel U., van Zee K., Muller J.M., Fanning E., Baeuerle P.A. Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-kappa B subunit. Cell 1992, 68:1121-1133.
13. Hinson J.S., Medlin M.D., Taylor J.M., Mack C.P. Regulation of myocardin factor protein stability by the LIM-only protein FHL2. Am J Physiol Heart Circ Physiol 2008, 295:H1067-H1075.
14. Huber S.C., MacKintosh C., Kaiser W.M. Metabolic enzymes as targets for 14-3-3 proteins. Plant Mol Biol 2002, 50:1053-1063.
15. Ito K., Hirao A., Arai F., Matsuoka S., Takubo K., Hamaguchi I, et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 2004, 431:997-1002.
16. Jalota A., Singh K., Pavithra L., Kaul-Ghanekar R., Jameel S., Chattopadhyay S. Tumor suppressor SMAR1 activates and stabilizes p53 through its arginine-serine-rich motif. J Biol Chem 2005, 280:16019-16029.
17. Jalota-Bhadwar A., Kaul-Ghanekar R., Mogare D., Bopanna R., Paknikar K.M., Chattopadhyay S. SMAR1- derived P44 peptide retains its tumor suppressor function through modulation of p53. J Biol Chem 2007, 282(13):9902-9913.
18. Jin J., Krishack P.A., Cao D. Role of aldo-keto reductases in development of prostate and breast cancer. Front Biosci 2006, 11:2767-2773.
19. Jin Y., Penning T.M. Aldo-keto reductases and bioactivation/detoxication. Annu Rev Pharmacol Toxicol 2007, 47:263-292.
20. Kaul-Ghanekar R., Majumdar S., Jalota A., Gulati N., Dubey N., Saha B., et al. Abnormal V(D)J recombination of T cell receptor beta locus in SMAR1 transgenic mice. J Biol Chem 2005, 280:9450-9459.
21. Kaul R., Mukherjee S., Ahmed F., Bhatt M.K., Chippa R., Galande S., et al. Direct interaction with and activation of p53 by SMAR1 retards cell-cycle progression at G2/M phase and delays tumor growth in mice. Int J Cancer 2003, 103:606-615.
22. Li D., Hinshelwood A., Gardner R., McGarvie G., Ellis E.M. Mouse aldo-keto reductase AKR7A5 protects V79 cells against 4-hydroxynonenal-induced apoptosis. Toxicology 2006, 226:172-180.
23. Luk E., Carroll M., Baker M., Culotta V.C. Manganese activation of superoxide dismutase 2 in Saccharomyces cerevisiae requires MTM1, a member of the mitochondrial carrier family. Proc Natl Acad Sci U S A 2003, 100:10353-10357.
24. Mathew R., Karp C.M., Beaudoin B., Vuong N., Chen G., Chen H.Y., et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009, 137(6):1062-1075.
25. Oberley L.W., Buettner G.R. Role of superoxide dismutase in cancer: a review. Cancer Res 1979, 39:1141-1149.
26. Pavithra L., Singh S., Sreenath K., Chattopadhyay S. Tumor suppressor SMAR1 downregulates Cytokeratin 8 expression by displacing p53 from its cognate site. Int J Biochem Cell Biol 2009, 41:862-871.
27. Pavithra L, Sreenath K, Singh S, Chattopadhyay S. ATM mediated induction and phosphorylation of SMAR1 modulates cell cycle by p53-rb activation. J Biol Chem (submitted for publication).
28. Penning T.M., Drury J.E. Human aldo-keto reductases: function, gene regulation, and single nucleotide polymorphisms. Arch Biochem Biophys 2007, 464:241-250.
29. Plebuch M., Soldan M., Hungerer C., Koch L., Maser E. Increased resistance of tumor cells to daunorubicin after transfection of cDNAs coding for anthracycline inactivating enzymes. Cancer Lett 2007, 255:49-56.
30. Rampalli S., Pavithra L., Bhatt A., Kundu T.K., Chattopadhyay S. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex. Mol Cell Biol 2005, 25:8415-8429.
31. Saha T., Rih J.K., Rosen E.M. BRCA1 down-regulates cellular levels of reactive oxygen species. FEBS Lett 2009, 583:1535-1543.
32. Salim A.S. Scavengers of oxygen-derived free radicals prolong survival in advanced colonic cancer. A new approach. Tumour Biol 1993, 14:9-17.
33. Salim A.S. Role of free radicals in gastrointestinal cancer. Singapore Med J 1996, 37:295-298.
34. Shaner L., Wegele H., Buchner J., Morano K.A. The yeast Hsp110 Sse1 functionally interacts with the Hsp70 chaperones Ssa and Ssb. J Biol Chem 2005, 280:41262-41269.
35. Shiloh Y., Tabor E., Becker Y. Abnormal response of ataxia-telangiectasia cells to agents that break the deoxyribose moiety of DNA via a targeted free radical mechanism. Carcinogenesis 1983, 4:1317-1322.
36. Shoichet B.K., Baase W.A., Kuroki R., Matthews B.W. A relationship between protein stability and protein function. Proc Natl Acad Sci U S A 1995, 92:452-456.
37. Singh K., Mogare D., Giridharagopalan R.O., Gogiraju R., Pande G., Chattopadhyay S. p53 target gene SMAR1 is dysregulated in breast cancer: its role in cancer cell migration and invasion. PLoS ONE 2007, 2:e660.
38. St Pierre J., Drori S., Uldry M., Silvaggi J.M., Rhee J., Jager S., et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006, 127:397-408.
39. Suzuki K., Koh Y.H., Mizuno H., Hamaoka R., Taniguchi N. Overexpression of aldehyde reductase protects PC12 cells from the cytotoxicity of methylglyoxal or 3-deoxyglucosone. J Biochem 1998, 123:353-357.
40. Tange T.O., Jensen T.H., Kjems J. In vitro interaction between human immunodeficiency virus type 1 Rev protein and splicing factor ASF/SF2-associated protein, p32. J Biol Chem 1996, 271:10066-10072.
41. Yan M., Zhu C., Liu N., Jiang Y., ScofieldVL, Riggs P.K., et al. ATM controls c-Myc and DNA synthesis during postnatal thymocyte development through regulation of redox state. Free Radic Biol Med 2006, 41:640-648.